-transparent.png){kind=logo}
The VP1 protein (23 kDa) of the foot-and-mouth disease virus has been produced in MC1061 and BL21 E. coli strains as beta-galactosidase fusion proteins, joined to either the amino and/or the carboxy termini of the bacterial enzyme. In BL21, devoid of La protease, all the recombinant fusion proteins are produced at higher yields than in MC1061, and occur mainly as inclusion bodies. The fusion of VP1 at the carboxy terminus yields a protease-sensitive protein whose degradation releases a stable, enzymatically active polypeptide indistinguishable from the native beta-galactosidase. On the contrary, when the same viral domain is fused to the amino terminus, the resulting chimeric protein is resistant to proteolysis even in the soluble form. These data demonstrate that the position of the heterologous domain in beta-galactosidase fusion proteins would not be irrelevant since it can dramatically influence properties of biotechnological interest such as solubility and proteolytic resistance.
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
October 1995,
Biotechnology and applied biochemistry,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
September 1984,
Gene,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
June 2005,
Comptes rendus biologies,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
January 1963,
Biochemische Zeitschrift,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
October 2003,
Journal of immunological methods,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
January 1996,
Biochimica et biophysica acta,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
July 2011,
Enzyme and microbial technology,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
September 2007,
FEMS microbiology letters,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
January 1994,
International reviews of immunology,
J L Corchero, and
E Viaplana, and
A Benito, and
A Villaverde
March 1974,
Nature,
